Cancer Center Support Grant Year 35 (CCSG) View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1977-2019

FUNDING AMOUNT

104136605 USD

ABSTRACT

The mission of the Comprehensive Cancer Center at St. Jude Children's Research Hospital (SJCCC) is to advance cures and means of prevention for pediatric cancer: the leading cause of disease-related death in children aged 1 to 14 years. For 36 of our 50 year history, we have pursued this mission with the support of a Cancer Center Support Grant from the National Cancer Institute (NCI). We remain the only NCI designated Cancer Center that is dedicated solely to the research and treatment of pediatric malignancies. As such, we serve as a national and international resource for health care providers, children with cancer, and their families. Through the support of the American Lebanese and Syrian Associated Charities (ALSAC), a separate corporation whose sole purpose is to raise money in support of St. Jude Children's Research Hospital (SJCRH), patients are accepted without regard to race, religion or ability to pay. Seventy-five percent of the total institutional space and annual budget are invested in the SJCCC. The current application proposes five multidisciplinary research Programs that are organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects: our three disease-oriented Programs focus on Developmental Biology and Solid Tumors (DBSTP), Hematological Malignancies (HMP), and Neurobiology and Brain Tumors (NBTP); our Cancer Prevention and Control Program (CPCP) strives to improve the quality of life of individuals surviving childhood cancer; and our new Cancer Genetics, Biochemistry and Cell Biology Program (CGBCBP), formed by merging our two prior basic laboratory research Programs, embeds basic cancer research within the heart of the SJCCC, facilitating direct interaction between the disease-oriented Programs and the major laboratory resources in the Center. Research by the 144 aligned members is supported by 10 Shared Resources and an outstanding clinical research infrastructure. During the previous funding period, a new Director was appointed and several enhancements were made to the overall structure, policies, and procedures of the SJCCC. 32,522 clinical trial enrollments occurred at the Center during the current funding period, of which 56% were to SJCCC investigator initiated studies. External peer reviewed trials, many which are SJCCC member-led, accounted for another 38% of enrollments. SJCCC members published more than 2,100 manuscripts during the funding period, and in the last 12 months were supported by $69.4 million in extramural funding ($57 million, peer-reviewed; $12.4 million, non-peer-reviewed). More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9439706

Related SciGraph Publications

  • 2019-12. Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells in BMC CANCER
  • 2019-12. A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-12. Analysis of error profiles in deep next-generation sequencing data in GENOME BIOLOGY
  • 2019-04-11. Correction to: H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo. in ACTA NEUROPATHOLOGICA
  • 2019-04. Genomic subtyping and therapeutic targeting of acute erythroleukemia in NATURE GENETICS
  • 2019-04. H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo in ACTA NEUROPATHOLOGICA
  • 2019-02. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia in NATURE GENETICS
  • 2019-02. Establishment of a transgenic mouse to model ETV7 expressing human tumors in TRANSGENIC RESEARCH
  • 2019-01. Structure and evolution of double minutes in diagnosis and relapse brain tumors in ACTA NEUROPATHOLOGICA
  • 2019-01. Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life in JOURNAL OF NEURO-ONCOLOGY
  • 2019-01. Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma in JOURNAL OF NEURO-ONCOLOGY
  • 2019-01. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity in NATURE
  • 2018-12-03. Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection in NATURE MICROBIOLOGY
  • 2018-12. UMI-count modeling and differential expression analysis for single-cell RNA sequencing in GENOME BIOLOGY
  • 2018-12. Time to diagnosis of pediatric brain tumors: a report from the Pediatric Hematology and Oncology Center in Rabat, Morocco in CHILD'S NERVOUS SYSTEM
  • 2018-12. Self-interaction of NPM1 modulates multiple mechanisms of liquid–liquid phase separation in NATURE COMMUNICATIONS
  • 2018-12. Mouse medulloblastoma driven by CRISPR activation of cellular Myc in SCIENTIFIC REPORTS
  • 2018-12. Compositional adaptability in NPM1-SURF6 scaffolding networks enabled by dynamic switching of phase separation mechanisms in NATURE COMMUNICATIONS
  • 2018-12. Murine hematopoietic stem cell activity is derived from pre-circulation embryos but not yolk sacs in NATURE COMMUNICATIONS
  • 2018-12. Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy in SCIENTIFIC REPORTS
  • 2018-12. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome in NATURE COMMUNICATIONS
  • 2018-10. Insurance, chronic health conditions, and utilization of primary and specialty outpatient services: a Childhood Cancer Survivor Study report in JOURNAL OF CANCER SURVIVORSHIP
  • 2018-10. The genetic basis and cell of origin of mixed phenotype acute leukaemia in NATURE
  • 2018-09-12. Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies in THE PHARMACOGENOMICS JOURNAL
  • 2018-08. Mental health insurance access and utilization among childhood cancer survivors: a report from the childhood cancer survivor study in JOURNAL OF CANCER SURVIVORSHIP
  • 2018-08. Workplace experiences and turnover intention among adult survivors of childhood cancer in JOURNAL OF CANCER SURVIVORSHIP
  • 2018-08. Targeting ALK in pediatric RMS does not induce antitumor activity in vivo in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-08. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous in ACTA NEUROPATHOLOGICA
  • 2018-07-02. Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms in LEUKEMIA
  • 2018-07. Importance ratings on patient-reported outcome items for survivorship care: comparison between pediatric cancer survivors, parents, and clinicians in QUALITY OF LIFE RESEARCH
  • 2018-06. Parent perspectives and preferences for strategies regarding nonsedated MRI scans in a pediatric oncology population in SUPPORTIVE CARE IN CANCER
  • 2018-06. Multiplex assessment of protein variant abundance by massively parallel sequencing in NATURE GENETICS
  • 2018-05. PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells in LEUKEMIA
  • 2018-05. Regulation of apoptosis by an intrinsically disordered region of Bcl-xL in NATURE CHEMICAL BIOLOGY
  • 2018-04. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma in ONCOGENE
  • 2018-04. Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases in CHILD'S NERVOUS SYSTEM
  • 2018-04. Posttraumatic stress-related psychological functioning in adult survivors of childhood cancer in JOURNAL OF CANCER SURVIVORSHIP
  • 2018-03. Pervasive phosphorus limitation of tree species but not communities in tropical forests in NATURE
  • 2018-03. The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data in CHILD'S NERVOUS SYSTEM
  • 2018-03. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours in NATURE
  • 2018-02. Epigenetic Drivers in Pediatric Medulloblastoma in THE CEREBELLUM
  • 2018-01. HNRNPH1 is required for rhabdomyosarcoma cell growth and survival in ONCOGENESIS
  • 2018-01. Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors in JOURNAL OF NEURO-ONCOLOGY
  • 2018-01. ABCB6, an ABC Transporter Impacting Drug Response and Disease in THE AAPS JOURNAL
  • 2018-01. Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life in BONE MARROW TRANSPLANTATION
  • 2017-12. The genomic landscape of pediatric myelodysplastic syndromes in NATURE COMMUNICATIONS
  • 2017-12. SPA70 is a potent antagonist of human pregnane X receptor in NATURE COMMUNICATIONS
  • 2017-12. The neoepitope landscape in pediatric cancers in GENOME MEDICINE
  • 2017-12. Role of Cytosolic Carboxypeptidase 5 in Neuronal Survival and Spermatogenesis in SCIENTIFIC REPORTS
  • 2017-12. Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma in SCIENTIFIC REPORTS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "104136605"
        }, 
        "description": "The mission of the Comprehensive Cancer Center at St. Jude Children's Research Hospital (SJCCC) is to advance cures and means of prevention for pediatric cancer: the leading cause of disease-related death in children aged 1 to 14 years. For 36 of our 50 year history, we have pursued this mission with the support of a Cancer Center Support Grant from the National Cancer Institute (NCI). We remain the only NCI designated Cancer Center that is dedicated solely to the research and treatment of pediatric malignancies. As such, we serve as a national and international resource for health care providers, children with cancer, and their families. Through the support of the American Lebanese and Syrian Associated Charities (ALSAC), a separate corporation whose sole purpose is to raise money in support of St. Jude Children's Research Hospital (SJCRH), patients are accepted without regard to race, religion or ability to pay. Seventy-five percent of the total institutional space and annual budget are invested in the SJCCC. The current application proposes five multidisciplinary research Programs that are organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects: our three disease-oriented Programs focus on Developmental Biology and Solid Tumors (DBSTP), Hematological Malignancies (HMP), and Neurobiology and Brain Tumors (NBTP); our Cancer Prevention and Control Program (CPCP) strives to improve the quality of life of individuals surviving childhood cancer; and our new Cancer Genetics, Biochemistry and Cell Biology Program (CGBCBP), formed by merging our two prior basic laboratory research Programs, embeds basic cancer research within the heart of the SJCCC, facilitating direct interaction between the disease-oriented Programs and the major laboratory resources in the Center. Research by the 144 aligned members is supported by 10 Shared Resources and an outstanding clinical research infrastructure. During the previous funding period, a new Director was appointed and several enhancements were made to the overall structure, policies, and procedures of the SJCCC. 32,522 clinical trial enrollments occurred at the Center during the current funding period, of which 56% were to SJCCC investigator initiated studies. External peer reviewed trials, many which are SJCCC member-led, accounted for another 38% of enrollments. SJCCC members published more than 2,100 manuscripts during the funding period, and in the last 12 months were supported by $69.4 million in extramural funding ($57 million, peer-reviewed; $12.4 million, non-peer-reviewed).", 
        "endDate": "2019-02-28T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438833", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438833"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA021765"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "Cell Biology Program", 
          "cancer", 
          "cancer prevention", 
          "research", 
          "years", 
          "international resources", 
          "major laboratory resources", 
          "race", 
          "prevention", 
          "DBSTP", 
          "long-term side effects", 
          "procedure", 
          "comprehensive cancer center", 
          "children", 
          "SJCCC investigator", 
          "biochemistry", 
          "heart", 
          "NBTP", 
          "pediatric cancer", 
          "HMP", 
          "means", 
          "St. Jude Children's Research Hospital", 
          "enrollment", 
          "basic cancer research", 
          "CCSG", 
          "trials", 
          "control programs", 
          "new Cancer Genetics", 
          "family", 
          "current funding period", 
          "religion", 
          "external peers", 
          "months", 
          "Syrian Associated Charities", 
          "ALSAC", 
          "developmental biology", 
          "aligned members", 
          "National Cancer Institute", 
          "money", 
          "peer", 
          "death", 
          "CPCP", 
          "percent", 
          "cause", 
          "hematological malignancies", 
          "pediatric malignancies", 
          "funding period", 
          "basic science discoveries", 
          "individuals", 
          "outstanding clinical research infrastructure", 
          "Shared Resources", 
          "treatment", 
          "SJCCC members", 
          "center", 
          "overall structure", 
          "quality", 
          "extramural funding", 
          "cure", 
          "cancer center", 
          "previous funding period", 
          "year history", 
          "prior basic laboratory research Programs", 
          "Solid Tumors", 
          "sole purpose", 
          "current applications", 
          "new director", 
          "several enhancements", 
          "annual budget", 
          "mission", 
          "childhood cancer", 
          "multidisciplinary research program", 
          "specific intent", 
          "clinical trial enrollment", 
          "life", 
          "support", 
          "disease", 
          "patients", 
          "Cancer Center Support Grant", 
          "curative therapy", 
          "health care providers", 
          "total institutional space", 
          "only NCI", 
          "ability", 
          "direct interaction", 
          "manuscript", 
          "separate corporation", 
          "Programs", 
          "neurobiology", 
          "CGBCBP", 
          "SJCCC", 
          "study", 
          "policy", 
          "regard", 
          "Brain Tumors"
        ], 
        "name": "Cancer Center Support Grant Year 35 (CCSG)", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.240871.8", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.240871.8", 
              "name": "ST. JUDE CHILDREN'S RESEARCH HOSPITAL", 
              "type": "Organization"
            }, 
            "familyName": "ROBERTS", 
            "givenName": "CHARLES", 
            "id": "sg:person.012404741132.65", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.012404741132.65", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438833"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "1977-09-01T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9439706"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438833'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438833'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438833'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438833'


     

    This table displays all metadata directly associated to this object as RDF triples.

    138 TRIPLES      19 PREDICATES      116 URIs      108 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438833 schema:about anzsrc-for:2211
    2 schema:amount Ncba47bfe487f4f86a8bd99d7bd8d4863
    3 schema:description The mission of the Comprehensive Cancer Center at St. Jude Children's Research Hospital (SJCCC) is to advance cures and means of prevention for pediatric cancer: the leading cause of disease-related death in children aged 1 to 14 years. For 36 of our 50 year history, we have pursued this mission with the support of a Cancer Center Support Grant from the National Cancer Institute (NCI). We remain the only NCI designated Cancer Center that is dedicated solely to the research and treatment of pediatric malignancies. As such, we serve as a national and international resource for health care providers, children with cancer, and their families. Through the support of the American Lebanese and Syrian Associated Charities (ALSAC), a separate corporation whose sole purpose is to raise money in support of St. Jude Children's Research Hospital (SJCRH), patients are accepted without regard to race, religion or ability to pay. Seventy-five percent of the total institutional space and annual budget are invested in the SJCCC. The current application proposes five multidisciplinary research Programs that are organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects: our three disease-oriented Programs focus on Developmental Biology and Solid Tumors (DBSTP), Hematological Malignancies (HMP), and Neurobiology and Brain Tumors (NBTP); our Cancer Prevention and Control Program (CPCP) strives to improve the quality of life of individuals surviving childhood cancer; and our new Cancer Genetics, Biochemistry and Cell Biology Program (CGBCBP), formed by merging our two prior basic laboratory research Programs, embeds basic cancer research within the heart of the SJCCC, facilitating direct interaction between the disease-oriented Programs and the major laboratory resources in the Center. Research by the 144 aligned members is supported by 10 Shared Resources and an outstanding clinical research infrastructure. During the previous funding period, a new Director was appointed and several enhancements were made to the overall structure, policies, and procedures of the SJCCC. 32,522 clinical trial enrollments occurred at the Center during the current funding period, of which 56% were to SJCCC investigator initiated studies. External peer reviewed trials, many which are SJCCC member-led, accounted for another 38% of enrollments. SJCCC members published more than 2,100 manuscripts during the funding period, and in the last 12 months were supported by $69.4 million in extramural funding ($57 million, peer-reviewed; $12.4 million, non-peer-reviewed).
    4 schema:endDate 2019-02-28T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier Nae05d6af6786401e8e3663eef1c01653
    7 Ncf7c091d5d244dfbbda1b27693092fea
    8 schema:inLanguage en
    9 schema:keywords ALSAC
    10 Brain Tumors
    11 CCSG
    12 CGBCBP
    13 CPCP
    14 Cancer Center Support Grant
    15 Cell Biology Program
    16 DBSTP
    17 HMP
    18 NBTP
    19 National Cancer Institute
    20 Programs
    21 SJCCC
    22 SJCCC investigator
    23 SJCCC members
    24 Shared Resources
    25 Solid Tumors
    26 St. Jude Children's Research Hospital
    27 Syrian Associated Charities
    28 ability
    29 aligned members
    30 annual budget
    31 basic cancer research
    32 basic science discoveries
    33 biochemistry
    34 cancer
    35 cancer center
    36 cancer prevention
    37 cause
    38 center
    39 childhood cancer
    40 children
    41 clinical trial enrollment
    42 comprehensive cancer center
    43 control programs
    44 curative therapy
    45 cure
    46 current applications
    47 current funding period
    48 death
    49 developmental biology
    50 direct interaction
    51 disease
    52 enrollment
    53 external peers
    54 extramural funding
    55 family
    56 funding period
    57 health care providers
    58 heart
    59 hematological malignancies
    60 individuals
    61 international resources
    62 life
    63 long-term side effects
    64 major laboratory resources
    65 manuscript
    66 means
    67 mission
    68 money
    69 months
    70 multidisciplinary research program
    71 neurobiology
    72 new Cancer Genetics
    73 new director
    74 only NCI
    75 outstanding clinical research infrastructure
    76 overall structure
    77 patients
    78 pediatric cancer
    79 pediatric malignancies
    80 peer
    81 percent
    82 policy
    83 prevention
    84 previous funding period
    85 prior basic laboratory research Programs
    86 procedure
    87 quality
    88 race
    89 regard
    90 religion
    91 research
    92 separate corporation
    93 several enhancements
    94 sole purpose
    95 specific intent
    96 study
    97 support
    98 total institutional space
    99 treatment
    100 trials
    101 year history
    102 years
    103 schema:name Cancer Center Support Grant Year 35 (CCSG)
    104 schema:recipient Nf7c365f7ad8f4eb4800785482df581e1
    105 sg:person.012404741132.65
    106 https://www.grid.ac/institutes/grid.240871.8
    107 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438833
    108 schema:sdDatePublished 2019-03-07T12:11
    109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    110 schema:sdPublisher N092aa56d3c7e4e05b04e55e41e962417
    111 schema:startDate 1977-09-01T00:00:00Z
    112 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9439706
    113 sgo:license sg:explorer/license/
    114 sgo:sdDataset grants
    115 rdf:type schema:MonetaryGrant
    116 N092aa56d3c7e4e05b04e55e41e962417 schema:name Springer Nature - SN SciGraph project
    117 rdf:type schema:Organization
    118 Nae05d6af6786401e8e3663eef1c01653 schema:name dimensions_id
    119 schema:value 2438833
    120 rdf:type schema:PropertyValue
    121 Ncba47bfe487f4f86a8bd99d7bd8d4863 schema:currency USD
    122 schema:value 104136605
    123 rdf:type schema:MonetaryAmount
    124 Ncf7c091d5d244dfbbda1b27693092fea schema:name nih_id
    125 schema:value P30CA021765
    126 rdf:type schema:PropertyValue
    127 Nf7c365f7ad8f4eb4800785482df581e1 schema:member sg:person.012404741132.65
    128 schema:roleName PI
    129 rdf:type schema:Role
    130 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    131 rdf:type schema:DefinedTerm
    132 sg:person.012404741132.65 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
    133 schema:familyName ROBERTS
    134 schema:givenName CHARLES
    135 rdf:type schema:Person
    136 https://www.grid.ac/institutes/grid.240871.8 schema:name ST. JUDE CHILDREN'S RESEARCH HOSPITAL
    137 rdf:type schema:Organization
    138 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...